Cargando…
Country-specific antibiotic use practices impact the human gut resistome
Despite increasing concerns over inappropriate use of antibiotics in medicine and food production, population-level resistance transfer into the human gut microbiota has not been demonstrated beyond individual case studies. To determine the “antibiotic resistance potential” for entire microbial comm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698509/ https://www.ncbi.nlm.nih.gov/pubmed/23568836 http://dx.doi.org/10.1101/gr.155465.113 |
_version_ | 1782275300807147520 |
---|---|
author | Forslund, Kristoffer Sunagawa, Shinichi Kultima, Jens Roat Mende, Daniel R. Arumugam, Manimozhiyan Typas, Athanasios Bork, Peer |
author_facet | Forslund, Kristoffer Sunagawa, Shinichi Kultima, Jens Roat Mende, Daniel R. Arumugam, Manimozhiyan Typas, Athanasios Bork, Peer |
author_sort | Forslund, Kristoffer |
collection | PubMed |
description | Despite increasing concerns over inappropriate use of antibiotics in medicine and food production, population-level resistance transfer into the human gut microbiota has not been demonstrated beyond individual case studies. To determine the “antibiotic resistance potential” for entire microbial communities, we employ metagenomic data and quantify the totality of known resistance genes in each community (its resistome) for 68 classes and subclasses of antibiotics. In 252 fecal metagenomes from three countries, we show that the most abundant resistance determinants are those for antibiotics also used in animals and for antibiotics that have been available longer. Resistance genes are also more abundant in samples from Spain, Italy, and France than from Denmark, the United States, or Japan. Where comparable country-level data on antibiotic use in both humans and animals are available, differences in these statistics match the observed resistance potential differences. The results are robust over time as the antibiotic resistance determinants of individuals persist in the human gut flora for at least a year. |
format | Online Article Text |
id | pubmed-3698509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36985092014-01-01 Country-specific antibiotic use practices impact the human gut resistome Forslund, Kristoffer Sunagawa, Shinichi Kultima, Jens Roat Mende, Daniel R. Arumugam, Manimozhiyan Typas, Athanasios Bork, Peer Genome Res Research Despite increasing concerns over inappropriate use of antibiotics in medicine and food production, population-level resistance transfer into the human gut microbiota has not been demonstrated beyond individual case studies. To determine the “antibiotic resistance potential” for entire microbial communities, we employ metagenomic data and quantify the totality of known resistance genes in each community (its resistome) for 68 classes and subclasses of antibiotics. In 252 fecal metagenomes from three countries, we show that the most abundant resistance determinants are those for antibiotics also used in animals and for antibiotics that have been available longer. Resistance genes are also more abundant in samples from Spain, Italy, and France than from Denmark, the United States, or Japan. Where comparable country-level data on antibiotic use in both humans and animals are available, differences in these statistics match the observed resistance potential differences. The results are robust over time as the antibiotic resistance determinants of individuals persist in the human gut flora for at least a year. Cold Spring Harbor Laboratory Press 2013-07 /pmc/articles/PMC3698509/ /pubmed/23568836 http://dx.doi.org/10.1101/gr.155465.113 Text en © 2013, Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/. |
spellingShingle | Research Forslund, Kristoffer Sunagawa, Shinichi Kultima, Jens Roat Mende, Daniel R. Arumugam, Manimozhiyan Typas, Athanasios Bork, Peer Country-specific antibiotic use practices impact the human gut resistome |
title | Country-specific antibiotic use practices impact the human gut resistome |
title_full | Country-specific antibiotic use practices impact the human gut resistome |
title_fullStr | Country-specific antibiotic use practices impact the human gut resistome |
title_full_unstemmed | Country-specific antibiotic use practices impact the human gut resistome |
title_short | Country-specific antibiotic use practices impact the human gut resistome |
title_sort | country-specific antibiotic use practices impact the human gut resistome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698509/ https://www.ncbi.nlm.nih.gov/pubmed/23568836 http://dx.doi.org/10.1101/gr.155465.113 |
work_keys_str_mv | AT forslundkristoffer countryspecificantibioticusepracticesimpactthehumangutresistome AT sunagawashinichi countryspecificantibioticusepracticesimpactthehumangutresistome AT kultimajensroat countryspecificantibioticusepracticesimpactthehumangutresistome AT mendedanielr countryspecificantibioticusepracticesimpactthehumangutresistome AT arumugammanimozhiyan countryspecificantibioticusepracticesimpactthehumangutresistome AT typasathanasios countryspecificantibioticusepracticesimpactthehumangutresistome AT borkpeer countryspecificantibioticusepracticesimpactthehumangutresistome |